The 2022 Richard Lane/Robert Holden Patient Advocacy Award was presented at an Awards Reception held in conjunction with the 2022 Conference of the American Association for the Treatment of Opioid Dependence (AATOD) in Baltimore, Maryland on November 2, 2022. Richard Lane/Robert Holden Patient Advocacy Award Richard Lane was a long-term heroin user who, upon release…
Read more
Whereas, substance use disorders are a serious and treatable public health problem affecting thousand of Americans of all ages, races, ethnic backgrounds and having huge medical ,societal and economic costs; and Whereas, methadone treatment is the “gold standard” for all drug and alcohol treatments and yet is misunderstood because of years of prejudice and…
American Association for the Treatment of Opioid Dependence Washington, D.C. ~ April 13-16, 2003 Honorary Patient Recognition The Honorary Methadone Patient was developed by the National Alliance of Methadone Advocates to recognize those special persons who are not patients but in addition to making significant contributions to the field do so to help patients. Dr….
National Alliance of Methadone Advocates 435 Second Avenue New York, NY 10010 Phone: (212) 595-6262 Review Guidelines for the Federation of State Medical Boards Model Policy Guidelines for Opioid Addiction Treatment in the Medical Office Section I Preamble Paragraph 2 The second sentence should also include the fact that Medical Maintenance has been demonstrated to…
National Alliance of Methadone Advocates Dear Advocates: Since its beginning over 30 years ago methadone maintenance has been the preferred treatment for narcotic addiction by the drug user. Many times it has been demonstrated to be the most effective treatment for heroin addiction, resulting in the termination both of heroin use and of criminal behavior. …
Membership Application Name: _______________________________________________________ Mr. ___ Ms. ___ Dr. ___ Organization: __________________________________________________________________________ Title: _____________________________________________ Degree(s): ________________________ Address: _____________________________________________________________________________ Address: _____________________________________________________________________________ City: __________________________________ State: ____________ Postal Code: _____________ Email: ______________________________________ Country: ________________________________ Home Phone: (____)___________________________ Work Phone: (____)_______________________ Alternate Phone: (____)________________________ Fax: (____)______________________________ If you have email may we send you bulletin alerts electronically. (This will get bulletin alerts to you quicker than usual mail) Yes _____ No _____ Types of Membership $_______ Individual Membership Dues: $25 a…
October 9, 2002 NIDA Contact: Michelle Person 301-443-6245 SAMHSA Contact: Leah Young 301-443-8956 NIDA Research and SAMHSA Physician Training Combine to Put Care for Opiate Dependence in Hands of Family Doctor. Buprenorphine, a new medication developed through more than a decade of research supported by the National Institute on Drug Abuse (NIDA), will now become…
